glp-1 vs glp vs. Peptide Therapy: What's the Difference—and Which Is Right for You? Current Insights, Advantages and Challenges
Description
Source: Heymsfield et al., JAMA, 2021
These innovative treatments tackle the biological challenges of weight loss, helping you reach and sustain your goals
One of the questions Ive been getting a lot is about how the new GLP-1 weight loss drugs (Novos Semaglutide Wegovy) and GLP-1/GIP co-agonist weight loss drugs (Lillys Tirzepatide/Zepbound) can interfere with the absorption of other medications
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
The trouble is that the number of people who lost enough weight and kept it off was so small
The fatigue is real
